nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP3A4—breast cancer	0.201	1	CbGaD
Guanfacine—CYP2C9—Anastrozole—breast cancer	0.0501	0.1	CbGbCtD
Guanfacine—CYP2C19—Lapatinib—breast cancer	0.0402	0.0803	CbGbCtD
Guanfacine—CYP3A4—Exemestane—breast cancer	0.0384	0.0768	CbGbCtD
Guanfacine—CYP2C9—Idarubicin—breast cancer	0.0379	0.0758	CbGbCtD
Guanfacine—CYP3A4—Letrozole—breast cancer	0.0327	0.0653	CbGbCtD
Guanfacine—CYP3A4—Anastrozole—breast cancer	0.0291	0.0582	CbGbCtD
Guanfacine—CYP3A4—Toremifene—breast cancer	0.0266	0.0532	CbGbCtD
Guanfacine—CYP3A4—Fulvestrant—breast cancer	0.0248	0.0495	CbGbCtD
Guanfacine—CYP3A4—Thiotepa—breast cancer	0.0221	0.0441	CbGbCtD
Guanfacine—CYP2C9—Capecitabine—breast cancer	0.0208	0.0416	CbGbCtD
Guanfacine—CYP3A4—Ixabepilone—breast cancer	0.0202	0.0403	CbGbCtD
Guanfacine—CYP2C19—Tamoxifen—breast cancer	0.0201	0.0402	CbGbCtD
Guanfacine—CYP3A4—Lapatinib—breast cancer	0.0194	0.0388	CbGbCtD
Guanfacine—CYP2C9—Tamoxifen—breast cancer	0.0167	0.0334	CbGbCtD
Guanfacine—CYP3A4—Raloxifene—breast cancer	0.0147	0.0294	CbGbCtD
Guanfacine—CYP2C9—Paclitaxel—breast cancer	0.013	0.026	CbGbCtD
Guanfacine—CYP2C9—Fluorouracil—breast cancer	0.0123	0.0246	CbGbCtD
Guanfacine—CYP3A4—Vinorelbine—breast cancer	0.0108	0.0215	CbGbCtD
Guanfacine—CYP3A4—Tamoxifen—breast cancer	0.00973	0.0194	CbGbCtD
Guanfacine—CYP3A4—Mitoxantrone—breast cancer	0.00949	0.019	CbGbCtD
Guanfacine—CYP3A4—Paclitaxel—breast cancer	0.00757	0.0151	CbGbCtD
Guanfacine—CYP3A4—Irinotecan—breast cancer	0.00747	0.0149	CbGbCtD
Guanfacine—CYP3A4—Vinblastine—breast cancer	0.00664	0.0133	CbGbCtD
Guanfacine—CYP3A4—Docetaxel—breast cancer	0.00547	0.0109	CbGbCtD
Guanfacine—CYP3A4—Doxorubicin—breast cancer	0.00408	0.00815	CbGbCtD
Guanfacine—NISCH—Paclitaxel—Docetaxel—breast cancer	0.00169	0.358	CbGdCrCtD
Guanfacine—NISCH—mammary gland—breast cancer	0.00167	0.137	CbGeAlD
Guanfacine—NISCH—nipple—breast cancer	0.00138	0.114	CbGeAlD
Guanfacine—NISCH—Vincristine—Vinorelbine—breast cancer	0.00116	0.246	CbGdCrCtD
Guanfacine—NISCH—Vinblastine—Vinorelbine—breast cancer	0.000936	0.198	CbGdCrCtD
Guanfacine—NISCH—Vincristine—Vinblastine—breast cancer	0.00093	0.197	CbGdCrCtD
Guanfacine—Diclofenac—ABCC1—breast cancer	0.000837	0.269	CrCbGaD
Guanfacine—NISCH—uterus—breast cancer	0.000768	0.0632	CbGeAlD
Guanfacine—NISCH—pituitary gland—breast cancer	0.000754	0.062	CbGeAlD
Guanfacine—NISCH—adipose tissue—breast cancer	0.000751	0.0618	CbGeAlD
Guanfacine—Diclofenac—CXCL8—breast cancer	0.00074	0.238	CrCbGaD
Guanfacine—NISCH—adrenal gland—breast cancer	0.000674	0.0554	CbGeAlD
Guanfacine—NISCH—bone marrow—breast cancer	0.000652	0.0536	CbGeAlD
Guanfacine—NISCH—female gonad—breast cancer	0.000628	0.0517	CbGeAlD
Guanfacine—CYP2C9—mammary gland—breast cancer	0.000628	0.0516	CbGeAlD
Guanfacine—ADRA2A—nipple—breast cancer	0.000503	0.0414	CbGeAlD
Guanfacine—NISCH—lymph node—breast cancer	0.000404	0.0332	CbGeAlD
Guanfacine—Diclofenac—PTGS1—breast cancer	0.000378	0.121	CrCbGaD
Guanfacine—Diclofenac—CYP1A1—breast cancer	0.000345	0.111	CrCbGaD
Guanfacine—ADRA2A—endometrium—breast cancer	0.000304	0.025	CbGeAlD
Guanfacine—CYP2C19—endocrine gland—breast cancer	0.000284	0.0233	CbGeAlD
Guanfacine—ADRA2A—uterus—breast cancer	0.00028	0.023	CbGeAlD
Guanfacine—ADRA2A—pituitary gland—breast cancer	0.000275	0.0226	CbGeAlD
Guanfacine—ADRA2A—adipose tissue—breast cancer	0.000274	0.0225	CbGeAlD
Guanfacine—CYP2C9—female reproductive system—breast cancer	0.00026	0.0214	CbGeAlD
Guanfacine—ADRA2A—female reproductive system—breast cancer	0.000252	0.0207	CbGeAlD
Guanfacine—ADRA2A—adrenal gland—breast cancer	0.000246	0.0202	CbGeAlD
Guanfacine—ADRA2A—female gonad—breast cancer	0.000229	0.0188	CbGeAlD
Guanfacine—Diclofenac—CYP3A4—breast cancer	0.00022	0.0708	CrCbGaD
Guanfacine—CYP2C9—endocrine gland—breast cancer	0.00022	0.0181	CbGeAlD
Guanfacine—Diclofenac—PTGS2—breast cancer	0.000216	0.0694	CrCbGaD
Guanfacine—ADRA2A—endocrine gland—breast cancer	0.000213	0.0175	CbGeAlD
Guanfacine—CYP3A4—female reproductive system—breast cancer	0.000198	0.0163	CbGeAlD
Guanfacine—Diclofenac—ALB—breast cancer	0.000192	0.0618	CrCbGaD
Guanfacine—Diclofenac—ABCB1—breast cancer	0.000184	0.059	CrCbGaD
Guanfacine—CYP3A4—endocrine gland—breast cancer	0.000168	0.0138	CbGeAlD
Guanfacine—ADRA2A—lymph node—breast cancer	0.000147	0.0121	CbGeAlD
Guanfacine—Oedema—Docetaxel—breast cancer	8.74e-05	0.000395	CcSEcCtD
Guanfacine—Weight increased—Doxorubicin—breast cancer	8.73e-05	0.000394	CcSEcCtD
Guanfacine—Discomfort—Capecitabine—breast cancer	8.72e-05	0.000394	CcSEcCtD
Guanfacine—Pruritus—Gemcitabine—breast cancer	8.71e-05	0.000394	CcSEcCtD
Guanfacine—Nausea—Thiotepa—breast cancer	8.7e-05	0.000393	CcSEcCtD
Guanfacine—Diarrhoea—Mitoxantrone—breast cancer	8.65e-05	0.000391	CcSEcCtD
Guanfacine—Diarrhoea—Irinotecan—breast cancer	8.65e-05	0.000391	CcSEcCtD
Guanfacine—Dry mouth—Capecitabine—breast cancer	8.63e-05	0.00039	CcSEcCtD
Guanfacine—Shock—Docetaxel—breast cancer	8.6e-05	0.000388	CcSEcCtD
Guanfacine—Pruritus—Fluorouracil—breast cancer	8.57e-05	0.000387	CcSEcCtD
Guanfacine—Drowsiness—Doxorubicin—breast cancer	8.55e-05	0.000386	CcSEcCtD
Guanfacine—Visual impairment—Methotrexate—breast cancer	8.54e-05	0.000386	CcSEcCtD
Guanfacine—Confusional state—Capecitabine—breast cancer	8.53e-05	0.000385	CcSEcCtD
Guanfacine—Tachycardia—Docetaxel—breast cancer	8.53e-05	0.000385	CcSEcCtD
Guanfacine—Feeling abnormal—Paclitaxel—breast cancer	8.5e-05	0.000384	CcSEcCtD
Guanfacine—Oedema—Capecitabine—breast cancer	8.46e-05	0.000382	CcSEcCtD
Guanfacine—Bradycardia—Epirubicin—breast cancer	8.45e-05	0.000382	CcSEcCtD
Guanfacine—Gastrointestinal pain—Paclitaxel—breast cancer	8.43e-05	0.000381	CcSEcCtD
Guanfacine—Diarrhoea—Gemcitabine—breast cancer	8.43e-05	0.000381	CcSEcCtD
Guanfacine—Dizziness—Irinotecan—breast cancer	8.36e-05	0.000378	CcSEcCtD
Guanfacine—Shock—Capecitabine—breast cancer	8.32e-05	0.000376	CcSEcCtD
Guanfacine—Rhinitis—Epirubicin—breast cancer	8.32e-05	0.000376	CcSEcCtD
Guanfacine—Conjunctivitis—Doxorubicin—breast cancer	8.31e-05	0.000376	CcSEcCtD
Guanfacine—Eye disorder—Methotrexate—breast cancer	8.29e-05	0.000374	CcSEcCtD
Guanfacine—Diarrhoea—Fluorouracil—breast cancer	8.28e-05	0.000374	CcSEcCtD
Guanfacine—Tinnitus—Methotrexate—breast cancer	8.27e-05	0.000374	CcSEcCtD
Guanfacine—Tachycardia—Capecitabine—breast cancer	8.26e-05	0.000373	CcSEcCtD
Guanfacine—Sweating—Doxorubicin—breast cancer	8.2e-05	0.00037	CcSEcCtD
Guanfacine—Hyperhidrosis—Capecitabine—breast cancer	8.18e-05	0.00037	CcSEcCtD
Guanfacine—Hypotension—Docetaxel—breast cancer	8.17e-05	0.000369	CcSEcCtD
Guanfacine—Abdominal pain—Paclitaxel—breast cancer	8.15e-05	0.000368	CcSEcCtD
Guanfacine—Vomiting—Mitoxantrone—breast cancer	8.04e-05	0.000363	CcSEcCtD
Guanfacine—Vomiting—Irinotecan—breast cancer	8.04e-05	0.000363	CcSEcCtD
Guanfacine—Immune system disorder—Methotrexate—breast cancer	8.01e-05	0.000362	CcSEcCtD
Guanfacine—Dizziness—Fluorouracil—breast cancer	8.01e-05	0.000362	CcSEcCtD
Guanfacine—Visual impairment—Epirubicin—breast cancer	8e-05	0.000361	CcSEcCtD
Guanfacine—Rash—Mitoxantrone—breast cancer	7.97e-05	0.00036	CcSEcCtD
Guanfacine—Rash—Irinotecan—breast cancer	7.97e-05	0.00036	CcSEcCtD
Guanfacine—Dermatitis—Irinotecan—breast cancer	7.96e-05	0.00036	CcSEcCtD
Guanfacine—Dermatitis—Mitoxantrone—breast cancer	7.96e-05	0.00036	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Docetaxel—breast cancer	7.96e-05	0.00036	CcSEcCtD
Guanfacine—Headache—Mitoxantrone—breast cancer	7.92e-05	0.000358	CcSEcCtD
Guanfacine—Headache—Irinotecan—breast cancer	7.92e-05	0.000358	CcSEcCtD
Guanfacine—Hypotension—Capecitabine—breast cancer	7.91e-05	0.000357	CcSEcCtD
Guanfacine—Insomnia—Docetaxel—breast cancer	7.9e-05	0.000357	CcSEcCtD
Guanfacine—Paraesthesia—Docetaxel—breast cancer	7.85e-05	0.000355	CcSEcCtD
Guanfacine—Alopecia—Methotrexate—breast cancer	7.83e-05	0.000354	CcSEcCtD
Guanfacine—Vomiting—Gemcitabine—breast cancer	7.83e-05	0.000354	CcSEcCtD
Guanfacine—Bradycardia—Doxorubicin—breast cancer	7.82e-05	0.000353	CcSEcCtD
Guanfacine—Dyspnoea—Docetaxel—breast cancer	7.79e-05	0.000352	CcSEcCtD
Guanfacine—Somnolence—Docetaxel—breast cancer	7.77e-05	0.000351	CcSEcCtD
Guanfacine—Rash—Gemcitabine—breast cancer	7.76e-05	0.000351	CcSEcCtD
Guanfacine—Dermatitis—Gemcitabine—breast cancer	7.76e-05	0.000351	CcSEcCtD
Guanfacine—Eye disorder—Epirubicin—breast cancer	7.75e-05	0.00035	CcSEcCtD
Guanfacine—Tinnitus—Epirubicin—breast cancer	7.74e-05	0.00035	CcSEcCtD
Guanfacine—Headache—Gemcitabine—breast cancer	7.71e-05	0.000349	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Capecitabine—breast cancer	7.71e-05	0.000348	CcSEcCtD
Guanfacine—Vomiting—Fluorouracil—breast cancer	7.7e-05	0.000348	CcSEcCtD
Guanfacine—Rhinitis—Doxorubicin—breast cancer	7.7e-05	0.000348	CcSEcCtD
Guanfacine—Dyspepsia—Docetaxel—breast cancer	7.69e-05	0.000348	CcSEcCtD
Guanfacine—Insomnia—Capecitabine—breast cancer	7.65e-05	0.000346	CcSEcCtD
Guanfacine—Rash—Fluorouracil—breast cancer	7.63e-05	0.000345	CcSEcCtD
Guanfacine—Dermatitis—Fluorouracil—breast cancer	7.63e-05	0.000345	CcSEcCtD
Guanfacine—Paraesthesia—Capecitabine—breast cancer	7.6e-05	0.000343	CcSEcCtD
Guanfacine—Decreased appetite—Docetaxel—breast cancer	7.6e-05	0.000343	CcSEcCtD
Guanfacine—Hypersensitivity—Paclitaxel—breast cancer	7.6e-05	0.000343	CcSEcCtD
Guanfacine—Headache—Fluorouracil—breast cancer	7.59e-05	0.000343	CcSEcCtD
Guanfacine—Dysgeusia—Methotrexate—breast cancer	7.56e-05	0.000341	CcSEcCtD
Guanfacine—Dyspnoea—Capecitabine—breast cancer	7.54e-05	0.000341	CcSEcCtD
Guanfacine—Fatigue—Docetaxel—breast cancer	7.53e-05	0.00034	CcSEcCtD
Guanfacine—Nausea—Irinotecan—breast cancer	7.51e-05	0.000339	CcSEcCtD
Guanfacine—Nausea—Mitoxantrone—breast cancer	7.51e-05	0.000339	CcSEcCtD
Guanfacine—Immune system disorder—Epirubicin—breast cancer	7.49e-05	0.000339	CcSEcCtD
Guanfacine—Constipation—Docetaxel—breast cancer	7.47e-05	0.000338	CcSEcCtD
Guanfacine—Dyspepsia—Capecitabine—breast cancer	7.45e-05	0.000337	CcSEcCtD
Guanfacine—Visual impairment—Doxorubicin—breast cancer	7.4e-05	0.000334	CcSEcCtD
Guanfacine—Asthenia—Paclitaxel—breast cancer	7.4e-05	0.000334	CcSEcCtD
Guanfacine—Decreased appetite—Capecitabine—breast cancer	7.36e-05	0.000332	CcSEcCtD
Guanfacine—Alopecia—Epirubicin—breast cancer	7.33e-05	0.000331	CcSEcCtD
Guanfacine—Nausea—Gemcitabine—breast cancer	7.31e-05	0.000331	CcSEcCtD
Guanfacine—Fatigue—Capecitabine—breast cancer	7.29e-05	0.00033	CcSEcCtD
Guanfacine—Pruritus—Paclitaxel—breast cancer	7.29e-05	0.00033	CcSEcCtD
Guanfacine—Vision blurred—Methotrexate—breast cancer	7.27e-05	0.000329	CcSEcCtD
Guanfacine—Constipation—Capecitabine—breast cancer	7.24e-05	0.000327	CcSEcCtD
Guanfacine—Feeling abnormal—Docetaxel—breast cancer	7.2e-05	0.000325	CcSEcCtD
Guanfacine—Nausea—Fluorouracil—breast cancer	7.19e-05	0.000325	CcSEcCtD
Guanfacine—Eye disorder—Doxorubicin—breast cancer	7.17e-05	0.000324	CcSEcCtD
Guanfacine—Ill-defined disorder—Methotrexate—breast cancer	7.16e-05	0.000324	CcSEcCtD
Guanfacine—Tinnitus—Doxorubicin—breast cancer	7.16e-05	0.000323	CcSEcCtD
Guanfacine—Gastrointestinal pain—Docetaxel—breast cancer	7.15e-05	0.000323	CcSEcCtD
Guanfacine—Tension—Epirubicin—breast cancer	7.09e-05	0.00032	CcSEcCtD
Guanfacine—Dysgeusia—Epirubicin—breast cancer	7.07e-05	0.00032	CcSEcCtD
Guanfacine—Diarrhoea—Paclitaxel—breast cancer	7.05e-05	0.000319	CcSEcCtD
Guanfacine—Nervousness—Epirubicin—breast cancer	7.01e-05	0.000317	CcSEcCtD
Guanfacine—Feeling abnormal—Capecitabine—breast cancer	6.97e-05	0.000315	CcSEcCtD
Guanfacine—Malaise—Methotrexate—breast cancer	6.96e-05	0.000314	CcSEcCtD
Guanfacine—Muscle spasms—Epirubicin—breast cancer	6.94e-05	0.000314	CcSEcCtD
Guanfacine—Immune system disorder—Doxorubicin—breast cancer	6.93e-05	0.000313	CcSEcCtD
Guanfacine—Vertigo—Methotrexate—breast cancer	6.93e-05	0.000313	CcSEcCtD
Guanfacine—Gastrointestinal pain—Capecitabine—breast cancer	6.92e-05	0.000313	CcSEcCtD
Guanfacine—Abdominal pain—Docetaxel—breast cancer	6.91e-05	0.000312	CcSEcCtD
Guanfacine—Dizziness—Paclitaxel—breast cancer	6.82e-05	0.000308	CcSEcCtD
Guanfacine—Vision blurred—Epirubicin—breast cancer	6.81e-05	0.000308	CcSEcCtD
Guanfacine—Alopecia—Doxorubicin—breast cancer	6.78e-05	0.000307	CcSEcCtD
Guanfacine—Ill-defined disorder—Epirubicin—breast cancer	6.7e-05	0.000303	CcSEcCtD
Guanfacine—Abdominal pain—Capecitabine—breast cancer	6.69e-05	0.000302	CcSEcCtD
Guanfacine—Convulsion—Methotrexate—breast cancer	6.69e-05	0.000302	CcSEcCtD
Guanfacine—Agitation—Epirubicin—breast cancer	6.64e-05	0.0003	CcSEcCtD
Guanfacine—Chest pain—Methotrexate—breast cancer	6.57e-05	0.000297	CcSEcCtD
Guanfacine—Arthralgia—Methotrexate—breast cancer	6.57e-05	0.000297	CcSEcCtD
Guanfacine—Myalgia—Methotrexate—breast cancer	6.57e-05	0.000297	CcSEcCtD
Guanfacine—Tension—Doxorubicin—breast cancer	6.56e-05	0.000296	CcSEcCtD
Guanfacine—Vomiting—Paclitaxel—breast cancer	6.56e-05	0.000296	CcSEcCtD
Guanfacine—Dysgeusia—Doxorubicin—breast cancer	6.54e-05	0.000296	CcSEcCtD
Guanfacine—Malaise—Epirubicin—breast cancer	6.51e-05	0.000294	CcSEcCtD
Guanfacine—Rash—Paclitaxel—breast cancer	6.5e-05	0.000294	CcSEcCtD
Guanfacine—Dermatitis—Paclitaxel—breast cancer	6.49e-05	0.000293	CcSEcCtD
Guanfacine—Discomfort—Methotrexate—breast cancer	6.49e-05	0.000293	CcSEcCtD
Guanfacine—Nervousness—Doxorubicin—breast cancer	6.49e-05	0.000293	CcSEcCtD
Guanfacine—Vertigo—Epirubicin—breast cancer	6.49e-05	0.000293	CcSEcCtD
Guanfacine—Syncope—Epirubicin—breast cancer	6.48e-05	0.000293	CcSEcCtD
Guanfacine—Headache—Paclitaxel—breast cancer	6.46e-05	0.000292	CcSEcCtD
Guanfacine—Hypersensitivity—Docetaxel—breast cancer	6.44e-05	0.000291	CcSEcCtD
Guanfacine—Muscle spasms—Doxorubicin—breast cancer	6.42e-05	0.00029	CcSEcCtD
Guanfacine—Palpitations—Epirubicin—breast cancer	6.38e-05	0.000288	CcSEcCtD
Guanfacine—Confusional state—Methotrexate—breast cancer	6.35e-05	0.000287	CcSEcCtD
Guanfacine—Loss of consciousness—Epirubicin—breast cancer	6.35e-05	0.000287	CcSEcCtD
Guanfacine—Vision blurred—Doxorubicin—breast cancer	6.3e-05	0.000285	CcSEcCtD
Guanfacine—Asthenia—Docetaxel—breast cancer	6.27e-05	0.000283	CcSEcCtD
Guanfacine—Convulsion—Epirubicin—breast cancer	6.26e-05	0.000283	CcSEcCtD
Guanfacine—Hypertension—Epirubicin—breast cancer	6.24e-05	0.000282	CcSEcCtD
Guanfacine—Hypersensitivity—Capecitabine—breast cancer	6.23e-05	0.000282	CcSEcCtD
Guanfacine—Ill-defined disorder—Doxorubicin—breast cancer	6.2e-05	0.00028	CcSEcCtD
Guanfacine—Pruritus—Docetaxel—breast cancer	6.18e-05	0.000279	CcSEcCtD
Guanfacine—Myalgia—Epirubicin—breast cancer	6.15e-05	0.000278	CcSEcCtD
Guanfacine—Arthralgia—Epirubicin—breast cancer	6.15e-05	0.000278	CcSEcCtD
Guanfacine—Chest pain—Epirubicin—breast cancer	6.15e-05	0.000278	CcSEcCtD
Guanfacine—Agitation—Doxorubicin—breast cancer	6.14e-05	0.000277	CcSEcCtD
Guanfacine—Anxiety—Epirubicin—breast cancer	6.13e-05	0.000277	CcSEcCtD
Guanfacine—Nausea—Paclitaxel—breast cancer	6.12e-05	0.000277	CcSEcCtD
Guanfacine—Hyperhidrosis—Methotrexate—breast cancer	6.09e-05	0.000275	CcSEcCtD
Guanfacine—Discomfort—Epirubicin—breast cancer	6.08e-05	0.000275	CcSEcCtD
Guanfacine—Asthenia—Capecitabine—breast cancer	6.07e-05	0.000274	CcSEcCtD
Guanfacine—Malaise—Doxorubicin—breast cancer	6.03e-05	0.000272	CcSEcCtD
Guanfacine—Dry mouth—Epirubicin—breast cancer	6.01e-05	0.000272	CcSEcCtD
Guanfacine—Vertigo—Doxorubicin—breast cancer	6e-05	0.000271	CcSEcCtD
Guanfacine—Syncope—Doxorubicin—breast cancer	5.99e-05	0.000271	CcSEcCtD
Guanfacine—Pruritus—Capecitabine—breast cancer	5.99e-05	0.00027	CcSEcCtD
Guanfacine—Diarrhoea—Docetaxel—breast cancer	5.98e-05	0.00027	CcSEcCtD
Guanfacine—Confusional state—Epirubicin—breast cancer	5.94e-05	0.000269	CcSEcCtD
Guanfacine—Palpitations—Doxorubicin—breast cancer	5.91e-05	0.000267	CcSEcCtD
Guanfacine—Oedema—Epirubicin—breast cancer	5.89e-05	0.000266	CcSEcCtD
Guanfacine—Hypotension—Methotrexate—breast cancer	5.89e-05	0.000266	CcSEcCtD
Guanfacine—Loss of consciousness—Doxorubicin—breast cancer	5.87e-05	0.000265	CcSEcCtD
Guanfacine—Shock—Epirubicin—breast cancer	5.8e-05	0.000262	CcSEcCtD
Guanfacine—Convulsion—Doxorubicin—breast cancer	5.79e-05	0.000262	CcSEcCtD
Guanfacine—Diarrhoea—Capecitabine—breast cancer	5.79e-05	0.000262	CcSEcCtD
Guanfacine—Dizziness—Docetaxel—breast cancer	5.78e-05	0.000261	CcSEcCtD
Guanfacine—Hypertension—Doxorubicin—breast cancer	5.77e-05	0.000261	CcSEcCtD
Guanfacine—Tachycardia—Epirubicin—breast cancer	5.75e-05	0.00026	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Methotrexate—breast cancer	5.74e-05	0.000259	CcSEcCtD
Guanfacine—Hyperhidrosis—Epirubicin—breast cancer	5.7e-05	0.000257	CcSEcCtD
Guanfacine—Insomnia—Methotrexate—breast cancer	5.7e-05	0.000257	CcSEcCtD
Guanfacine—Chest pain—Doxorubicin—breast cancer	5.69e-05	0.000257	CcSEcCtD
Guanfacine—Myalgia—Doxorubicin—breast cancer	5.69e-05	0.000257	CcSEcCtD
Guanfacine—Arthralgia—Doxorubicin—breast cancer	5.69e-05	0.000257	CcSEcCtD
Guanfacine—Anxiety—Doxorubicin—breast cancer	5.67e-05	0.000256	CcSEcCtD
Guanfacine—Paraesthesia—Methotrexate—breast cancer	5.66e-05	0.000256	CcSEcCtD
Guanfacine—Discomfort—Doxorubicin—breast cancer	5.62e-05	0.000254	CcSEcCtD
Guanfacine—Dyspnoea—Methotrexate—breast cancer	5.62e-05	0.000254	CcSEcCtD
Guanfacine—Somnolence—Methotrexate—breast cancer	5.6e-05	0.000253	CcSEcCtD
Guanfacine—Dizziness—Capecitabine—breast cancer	5.6e-05	0.000253	CcSEcCtD
Guanfacine—Dry mouth—Doxorubicin—breast cancer	5.56e-05	0.000251	CcSEcCtD
Guanfacine—Vomiting—Docetaxel—breast cancer	5.56e-05	0.000251	CcSEcCtD
Guanfacine—Dyspepsia—Methotrexate—breast cancer	5.54e-05	0.000251	CcSEcCtD
Guanfacine—Rash—Docetaxel—breast cancer	5.51e-05	0.000249	CcSEcCtD
Guanfacine—Hypotension—Epirubicin—breast cancer	5.51e-05	0.000249	CcSEcCtD
Guanfacine—Dermatitis—Docetaxel—breast cancer	5.51e-05	0.000249	CcSEcCtD
Guanfacine—Confusional state—Doxorubicin—breast cancer	5.5e-05	0.000248	CcSEcCtD
Guanfacine—Decreased appetite—Methotrexate—breast cancer	5.48e-05	0.000247	CcSEcCtD
Guanfacine—Headache—Docetaxel—breast cancer	5.47e-05	0.000247	CcSEcCtD
Guanfacine—Oedema—Doxorubicin—breast cancer	5.45e-05	0.000246	CcSEcCtD
Guanfacine—Fatigue—Methotrexate—breast cancer	5.43e-05	0.000245	CcSEcCtD
Guanfacine—Vomiting—Capecitabine—breast cancer	5.38e-05	0.000243	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Epirubicin—breast cancer	5.37e-05	0.000243	CcSEcCtD
Guanfacine—Shock—Doxorubicin—breast cancer	5.37e-05	0.000242	CcSEcCtD
Guanfacine—Rash—Capecitabine—breast cancer	5.33e-05	0.000241	CcSEcCtD
Guanfacine—Insomnia—Epirubicin—breast cancer	5.33e-05	0.000241	CcSEcCtD
Guanfacine—Dermatitis—Capecitabine—breast cancer	5.33e-05	0.000241	CcSEcCtD
Guanfacine—Tachycardia—Doxorubicin—breast cancer	5.32e-05	0.000241	CcSEcCtD
Guanfacine—Headache—Capecitabine—breast cancer	5.3e-05	0.00024	CcSEcCtD
Guanfacine—Paraesthesia—Epirubicin—breast cancer	5.29e-05	0.000239	CcSEcCtD
Guanfacine—Hyperhidrosis—Doxorubicin—breast cancer	5.27e-05	0.000238	CcSEcCtD
Guanfacine—Dyspnoea—Epirubicin—breast cancer	5.26e-05	0.000237	CcSEcCtD
Guanfacine—Somnolence—Epirubicin—breast cancer	5.24e-05	0.000237	CcSEcCtD
Guanfacine—Nausea—Docetaxel—breast cancer	5.19e-05	0.000235	CcSEcCtD
Guanfacine—Feeling abnormal—Methotrexate—breast cancer	5.19e-05	0.000235	CcSEcCtD
Guanfacine—Dyspepsia—Epirubicin—breast cancer	5.19e-05	0.000234	CcSEcCtD
Guanfacine—Gastrointestinal pain—Methotrexate—breast cancer	5.15e-05	0.000233	CcSEcCtD
Guanfacine—Decreased appetite—Epirubicin—breast cancer	5.12e-05	0.000232	CcSEcCtD
Guanfacine—Hypotension—Doxorubicin—breast cancer	5.1e-05	0.00023	CcSEcCtD
Guanfacine—Fatigue—Epirubicin—breast cancer	5.08e-05	0.00023	CcSEcCtD
Guanfacine—Constipation—Epirubicin—breast cancer	5.04e-05	0.000228	CcSEcCtD
Guanfacine—Nausea—Capecitabine—breast cancer	5.03e-05	0.000227	CcSEcCtD
Guanfacine—Abdominal pain—Methotrexate—breast cancer	4.98e-05	0.000225	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.97e-05	0.000225	CcSEcCtD
Guanfacine—Insomnia—Doxorubicin—breast cancer	4.93e-05	0.000223	CcSEcCtD
Guanfacine—Paraesthesia—Doxorubicin—breast cancer	4.9e-05	0.000221	CcSEcCtD
Guanfacine—Dyspnoea—Doxorubicin—breast cancer	4.86e-05	0.00022	CcSEcCtD
Guanfacine—Feeling abnormal—Epirubicin—breast cancer	4.86e-05	0.000219	CcSEcCtD
Guanfacine—Somnolence—Doxorubicin—breast cancer	4.85e-05	0.000219	CcSEcCtD
Guanfacine—Gastrointestinal pain—Epirubicin—breast cancer	4.82e-05	0.000218	CcSEcCtD
Guanfacine—Dyspepsia—Doxorubicin—breast cancer	4.8e-05	0.000217	CcSEcCtD
Guanfacine—Decreased appetite—Doxorubicin—breast cancer	4.74e-05	0.000214	CcSEcCtD
Guanfacine—Fatigue—Doxorubicin—breast cancer	4.7e-05	0.000212	CcSEcCtD
Guanfacine—Constipation—Doxorubicin—breast cancer	4.66e-05	0.000211	CcSEcCtD
Guanfacine—Abdominal pain—Epirubicin—breast cancer	4.66e-05	0.000211	CcSEcCtD
Guanfacine—Hypersensitivity—Methotrexate—breast cancer	4.64e-05	0.00021	CcSEcCtD
Guanfacine—Asthenia—Methotrexate—breast cancer	4.52e-05	0.000204	CcSEcCtD
Guanfacine—Feeling abnormal—Doxorubicin—breast cancer	4.49e-05	0.000203	CcSEcCtD
Guanfacine—Gastrointestinal pain—Doxorubicin—breast cancer	4.46e-05	0.000202	CcSEcCtD
Guanfacine—Pruritus—Methotrexate—breast cancer	4.46e-05	0.000201	CcSEcCtD
Guanfacine—Hypersensitivity—Epirubicin—breast cancer	4.34e-05	0.000196	CcSEcCtD
Guanfacine—Abdominal pain—Doxorubicin—breast cancer	4.31e-05	0.000195	CcSEcCtD
Guanfacine—Diarrhoea—Methotrexate—breast cancer	4.31e-05	0.000195	CcSEcCtD
Guanfacine—Asthenia—Epirubicin—breast cancer	4.23e-05	0.000191	CcSEcCtD
Guanfacine—Pruritus—Epirubicin—breast cancer	4.17e-05	0.000188	CcSEcCtD
Guanfacine—Dizziness—Methotrexate—breast cancer	4.17e-05	0.000188	CcSEcCtD
Guanfacine—Diarrhoea—Epirubicin—breast cancer	4.03e-05	0.000182	CcSEcCtD
Guanfacine—Hypersensitivity—Doxorubicin—breast cancer	4.02e-05	0.000182	CcSEcCtD
Guanfacine—Vomiting—Methotrexate—breast cancer	4e-05	0.000181	CcSEcCtD
Guanfacine—Rash—Methotrexate—breast cancer	3.97e-05	0.000179	CcSEcCtD
Guanfacine—Dermatitis—Methotrexate—breast cancer	3.97e-05	0.000179	CcSEcCtD
Guanfacine—Headache—Methotrexate—breast cancer	3.95e-05	0.000178	CcSEcCtD
Guanfacine—Asthenia—Doxorubicin—breast cancer	3.91e-05	0.000177	CcSEcCtD
Guanfacine—Dizziness—Epirubicin—breast cancer	3.9e-05	0.000176	CcSEcCtD
Guanfacine—Pruritus—Doxorubicin—breast cancer	3.86e-05	0.000174	CcSEcCtD
Guanfacine—Vomiting—Epirubicin—breast cancer	3.75e-05	0.000169	CcSEcCtD
Guanfacine—Nausea—Methotrexate—breast cancer	3.74e-05	0.000169	CcSEcCtD
Guanfacine—Diarrhoea—Doxorubicin—breast cancer	3.73e-05	0.000169	CcSEcCtD
Guanfacine—Rash—Epirubicin—breast cancer	3.72e-05	0.000168	CcSEcCtD
Guanfacine—Dermatitis—Epirubicin—breast cancer	3.71e-05	0.000168	CcSEcCtD
Guanfacine—Headache—Epirubicin—breast cancer	3.69e-05	0.000167	CcSEcCtD
Guanfacine—Dizziness—Doxorubicin—breast cancer	3.61e-05	0.000163	CcSEcCtD
Guanfacine—Nausea—Epirubicin—breast cancer	3.5e-05	0.000158	CcSEcCtD
Guanfacine—Vomiting—Doxorubicin—breast cancer	3.47e-05	0.000157	CcSEcCtD
Guanfacine—Rash—Doxorubicin—breast cancer	3.44e-05	0.000155	CcSEcCtD
Guanfacine—Dermatitis—Doxorubicin—breast cancer	3.44e-05	0.000155	CcSEcCtD
Guanfacine—Headache—Doxorubicin—breast cancer	3.42e-05	0.000154	CcSEcCtD
Guanfacine—Nausea—Doxorubicin—breast cancer	3.24e-05	0.000146	CcSEcCtD
Guanfacine—CYP2C9—Metabolism—SLC2A1—breast cancer	6.4e-06	0.000112	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NQO1—breast cancer	6.4e-06	0.000112	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HES1—breast cancer	6.38e-06	0.000112	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOTCH1—breast cancer	6.35e-06	0.000111	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PLA2G4A—breast cancer	6.35e-06	0.000111	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NCOR1—breast cancer	6.35e-06	0.000111	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP19A1—breast cancer	6.32e-06	0.000111	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—STK11—breast cancer	6.32e-06	0.000111	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—TP53—breast cancer	6.28e-06	0.00011	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGF1—breast cancer	6.28e-06	0.00011	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CSF2—breast cancer	6.28e-06	0.00011	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.26e-06	0.00011	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—RAF1—breast cancer	6.26e-06	0.00011	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP3A4—breast cancer	6.24e-06	0.000109	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NRG1—breast cancer	6.23e-06	0.000109	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APC—breast cancer	6.21e-06	0.000109	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KIT—breast cancer	6.21e-06	0.000109	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CG—breast cancer	6.21e-06	0.000109	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.21e-06	0.000109	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CAV1—breast cancer	6.19e-06	0.000108	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—H2AFX—breast cancer	6.18e-06	0.000108	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—IL2—breast cancer	6.18e-06	0.000108	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—E2F1—breast cancer	6.14e-06	0.000108	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EGF—breast cancer	6.14e-06	0.000108	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP1B1—breast cancer	6.13e-06	0.000108	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CB—breast cancer	6.11e-06	0.000107	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HSP90AA1—breast cancer	6.01e-06	0.000105	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—HRAS—breast cancer	6.01e-06	0.000105	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—MAPK3—breast cancer	5.95e-06	0.000104	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.94e-06	0.000104	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SPP1—breast cancer	5.9e-06	0.000103	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—COMT—breast cancer	5.88e-06	0.000103	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CXCL8—breast cancer	5.87e-06	0.000103	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTP1—breast cancer	5.85e-06	0.000103	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NCOA1—breast cancer	5.85e-06	0.000103	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—BRAF—breast cancer	5.84e-06	0.000102	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ERBB3—breast cancer	5.84e-06	0.000102	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGFR2—breast cancer	5.83e-06	0.000102	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HMOX1—breast cancer	5.77e-06	0.000101	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—STK11—breast cancer	5.77e-06	0.000101	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP19A1—breast cancer	5.77e-06	0.000101	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ITPR1—breast cancer	5.76e-06	0.000101	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MED12—breast cancer	5.74e-06	0.000101	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—DPYD—breast cancer	5.74e-06	0.000101	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IGF1—breast cancer	5.69e-06	9.97e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT2—breast cancer	5.68e-06	9.96e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—EGFR—breast cancer	5.66e-06	9.92e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALDOA—breast cancer	5.65e-06	9.91e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CG—breast cancer	5.64e-06	9.88e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL2—breast cancer	5.61e-06	9.84e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TERT—breast cancer	5.59e-06	9.81e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ABCB1—breast cancer	5.54e-06	9.71e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NCOA3—breast cancer	5.49e-06	9.62e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CD—breast cancer	5.46e-06	9.57e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC2A2—breast cancer	5.45e-06	9.55e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—TYMS—breast cancer	5.44e-06	9.54e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGFR1—breast cancer	5.43e-06	9.52e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.41e-06	9.49e-05	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—PIK3CA—breast cancer	5.41e-06	9.48e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SERPINE1—breast cancer	5.4e-06	9.47e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NCOR1—breast cancer	5.38e-06	9.43e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PLA2G4A—breast cancer	5.38e-06	9.43e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTM1—breast cancer	5.38e-06	9.43e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—COMT—breast cancer	5.36e-06	9.4e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HIF1A—breast cancer	5.35e-06	9.38e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—KRAS—breast cancer	5.35e-06	9.37e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CPT1A—breast cancer	5.34e-06	9.36e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MTR—breast cancer	5.34e-06	9.36e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCG2—breast cancer	5.34e-06	9.36e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTP1—breast cancer	5.34e-06	9.36e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—AKT1—breast cancer	5.3e-06	9.3e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HMOX1—breast cancer	5.26e-06	9.23e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ITPR1—breast cancer	5.25e-06	9.21e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HPGDS—breast cancer	5.23e-06	9.18e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LEP—breast cancer	5.22e-06	9.16e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HBA1—breast cancer	5.2e-06	9.12e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CAV1—breast cancer	5.17e-06	9.07e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOS3—breast cancer	5.16e-06	9.04e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GPX1—breast cancer	5.15e-06	9.03e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KDR—breast cancer	5.12e-06	8.97e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP1A1—breast cancer	5.1e-06	8.94e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTT1—breast cancer	5.08e-06	8.9e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ACHE—breast cancer	5.08e-06	8.9e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ERCC2—breast cancer	5.06e-06	8.86e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ABCB1—breast cancer	5.05e-06	8.86e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ESR1—breast cancer	4.99e-06	8.74e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—TYMS—breast cancer	4.96e-06	8.7e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CD—breast cancer	4.95e-06	8.69e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FN1—breast cancer	4.92e-06	8.63e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PIK3CA—breast cancer	4.91e-06	8.61e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NCOR1—breast cancer	4.9e-06	8.6e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTM1—breast cancer	4.9e-06	8.6e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PLA2G4A—breast cancer	4.9e-06	8.6e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MDM2—breast cancer	4.89e-06	8.58e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ALB—breast cancer	4.89e-06	8.58e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RAF1—breast cancer	4.87e-06	8.55e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NFKBIA—breast cancer	4.87e-06	8.53e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RELA—breast cancer	4.85e-06	8.51e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ERBB2—breast cancer	4.82e-06	8.46e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOTCH1—breast cancer	4.82e-06	8.45e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP17A1—breast cancer	4.81e-06	8.43e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CB—breast cancer	4.76e-06	8.34e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MTOR—breast cancer	4.76e-06	8.34e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS1—breast cancer	4.76e-06	8.34e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ENO1—breast cancer	4.76e-06	8.34e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—MTHFR—breast cancer	4.75e-06	8.33e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APC—breast cancer	4.71e-06	8.26e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CG—breast cancer	4.71e-06	8.26e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KIT—breast cancer	4.71e-06	8.26e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GPX1—breast cancer	4.7e-06	8.23e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—NOS3—breast cancer	4.68e-06	8.2e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP2D6—breast cancer	4.66e-06	8.18e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EGF—breast cancer	4.66e-06	8.17e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP1A1—breast cancer	4.65e-06	8.15e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ERCC2—breast cancer	4.61e-06	8.08e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NCOA2—breast cancer	4.58e-06	8.03e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CXCL8—breast cancer	4.57e-06	8.02e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—HRAS—breast cancer	4.54e-06	7.97e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—MAPK3—breast cancer	4.51e-06	7.91e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CDKN1B—breast cancer	4.47e-06	7.83e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—FASN—breast cancer	4.44e-06	7.79e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—BRAF—breast cancer	4.43e-06	7.77e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—BCHE—breast cancer	4.42e-06	7.75e-05	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—AKT1—breast cancer	4.42e-06	7.75e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CAV1—breast cancer	4.38e-06	7.69e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CASP3—breast cancer	4.38e-06	7.68e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL2—breast cancer	4.37e-06	7.66e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC5A5—breast cancer	4.37e-06	7.66e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6—breast cancer	4.35e-06	7.63e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—MTHFR—breast cancer	4.33e-06	7.6e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CB—breast cancer	4.32e-06	7.57e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF1—breast cancer	4.31e-06	7.57e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT2—breast cancer	4.31e-06	7.56e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—EGFR—breast cancer	4.29e-06	7.53e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS2—breast cancer	4.28e-06	7.5e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCND1—breast cancer	4.26e-06	7.47e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—JUN—breast cancer	4.25e-06	7.46e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CTNNB1—breast cancer	4.22e-06	7.4e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC2A1—breast cancer	4.22e-06	7.4e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NQO1—breast cancer	4.22e-06	7.4e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.19e-06	7.34e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	4.14e-06	7.26e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MMP9—breast cancer	4.14e-06	7.25e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CDKN1A—breast cancer	4.12e-06	7.23e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PTEN—breast cancer	4.11e-06	7.21e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	4.1e-06	7.19e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	4.1e-06	7.18e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—KRAS—breast cancer	4.06e-06	7.11e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP1B1—breast cancer	4.04e-06	7.09e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK8—breast cancer	4.02e-06	7.05e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—AKT1—breast cancer	4.01e-06	7.03e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CAV1—breast cancer	4e-06	7.01e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CG—breast cancer	3.99e-06	7e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.97e-06	6.96e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOS3—breast cancer	3.91e-06	6.86e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NCOA1—breast cancer	3.86e-06	6.77e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.82e-06	6.7e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SRC—breast cancer	3.81e-06	6.69e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—STK11—breast cancer	3.8e-06	6.67e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP19A1—breast cancer	3.8e-06	6.67e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTEN—breast cancer	3.73e-06	6.54e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	3.73e-06	6.53e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—VEGFA—breast cancer	3.71e-06	6.51e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MDM2—breast cancer	3.71e-06	6.51e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RAF1—breast cancer	3.7e-06	6.48e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RELA—breast cancer	3.68e-06	6.46e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—STAT3—breast cancer	3.68e-06	6.45e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ERBB2—breast cancer	3.66e-06	6.42e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CG—breast cancer	3.64e-06	6.38e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MTOR—breast cancer	3.61e-06	6.33e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	3.61e-06	6.33e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—COMT—breast cancer	3.54e-06	6.2e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTP1—breast cancer	3.52e-06	6.17e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK3—breast cancer	3.51e-06	6.16e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CD—breast cancer	3.51e-06	6.15e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMOX1—breast cancer	3.47e-06	6.08e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	3.47e-06	6.08e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALB—breast cancer	3.46e-06	6.08e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ITPR1—breast cancer	3.46e-06	6.07e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	3.45e-06	6.04e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MYC—breast cancer	3.42e-06	5.99e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TGFB1—breast cancer	3.41e-06	5.98e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	3.39e-06	5.94e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	3.35e-06	5.88e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EGFR—breast cancer	3.34e-06	5.86e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCB1—breast cancer	3.33e-06	5.84e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CASP3—breast cancer	3.32e-06	5.82e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL2—breast cancer	3.32e-06	5.81e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NOS3—breast cancer	3.31e-06	5.81e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6—breast cancer	3.3e-06	5.79e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—TYMS—breast cancer	3.27e-06	5.74e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.23e-06	5.67e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTM1—breast cancer	3.23e-06	5.67e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NCOR1—breast cancer	3.23e-06	5.67e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCND1—breast cancer	3.23e-06	5.67e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—JUN—breast cancer	3.23e-06	5.66e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	3.2e-06	5.61e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CD—breast cancer	3.2e-06	5.61e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALB—breast cancer	3.16e-06	5.54e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KRAS—breast cancer	3.16e-06	5.54e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP9—breast cancer	3.14e-06	5.5e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	3.13e-06	5.48e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTEN—breast cancer	3.12e-06	5.47e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GPX1—breast cancer	3.1e-06	5.43e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP1A1—breast cancer	3.07e-06	5.37e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CB—breast cancer	3.06e-06	5.36e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	3.05e-06	5.35e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	3.04e-06	5.34e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ERCC2—breast cancer	3.04e-06	5.33e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS2—breast cancer	3.03e-06	5.32e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NOS3—breast cancer	3.02e-06	5.3e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	2.9e-06	5.09e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SRC—breast cancer	2.89e-06	5.07e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MTHFR—breast cancer	2.86e-06	5.01e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	2.82e-06	4.94e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TP53—breast cancer	2.81e-06	4.92e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—STAT3—breast cancer	2.79e-06	4.89e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CB—breast cancer	2.79e-06	4.89e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS2—breast cancer	2.76e-06	4.85e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HRAS—breast cancer	2.68e-06	4.71e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	2.67e-06	4.67e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTEN—breast cancer	2.64e-06	4.64e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CAV1—breast cancer	2.64e-06	4.62e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CA—breast cancer	2.63e-06	4.62e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MYC—breast cancer	2.59e-06	4.55e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	2.59e-06	4.54e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6—breast cancer	2.57e-06	4.5e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EGFR—breast cancer	2.54e-06	4.45e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTEN—breast cancer	2.41e-06	4.23e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CG—breast cancer	2.4e-06	4.21e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KRAS—breast cancer	2.4e-06	4.2e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT1—breast cancer	2.37e-06	4.16e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	2.2e-06	3.86e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AKT1—breast cancer	2.15e-06	3.77e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TP53—breast cancer	2.13e-06	3.73e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CD—breast cancer	2.11e-06	3.7e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALB—breast cancer	2.08e-06	3.65e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HRAS—breast cancer	2.04e-06	3.57e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NOS3—breast cancer	1.99e-06	3.49e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6—breast cancer	1.95e-06	3.42e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CA—breast cancer	1.87e-06	3.27e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.84e-06	3.23e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS2—breast cancer	1.82e-06	3.2e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT1—breast cancer	1.8e-06	3.15e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CA—breast cancer	1.7e-06	2.98e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTEN—breast cancer	1.59e-06	2.79e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKT1—breast cancer	1.52e-06	2.67e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKT1—breast cancer	1.39e-06	2.44e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CA—breast cancer	1.12e-06	1.97e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKT1—breast cancer	9.16e-07	1.61e-05	CbGpPWpGaD
